GSK reports promising early results in ovarian and womb cancer drug trial ⊖
found
a story from The Guardian ⚠️ › International
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug
GSK has revealed positive results for a treatment for gynaecological cancers as its chief executiv…